More importantly, the effects of VIM-AS1 on both cell lines were significantly reversed by miR-655, indicating that VIM-AS1 acts as a ceRNA to competitively bind to miR-655, therefore rescuing ZEB1 expression and promoting EMT and metastasis in bladder cancer cells (Fig. 7). The gene discussed is ZEB1; the disease is urinary bladder carcinoma.